The need for renal replacement therapy is currently rising at an annually increasing rate. Current treatment options for patients with end-stage kidney disease include dialysis or organ transplantation. Yet, even though transplant survival has increased due to refined immunosuppressive therapy, morbidity remains high because of organ shortage. Here we discuss a recent publication that describes the transplantation of a bioengineered biocompatible kidney from a decellularized organ scaffold, thus possibly providing a solution to both transplant organ shortage and morbidity associated with long-term immunosuppression. © 2013 Springer Science+Business Media.
CITATION STYLE
Kuppe, C., Berger, K., & Smeets, B. (2014, February). Bioengineered kidneys: New sights on a distant horizon. International Urology and Nephrology. https://doi.org/10.1007/s11255-013-0570-4
Mendeley helps you to discover research relevant for your work.